Sponsor content
81 result(s) found, displaying 61 to 70
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2021
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEDITAB SIMVASTATIN simvastatin 10 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEDITAB SIMVASTATIN simvastatin 40 mg tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEDITAB SIMVASTATIN simvastatin 80 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEDITAB SIMVASTATIN simvastatin10 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEDITAB SIMVASTATIN simvastatin 80 mg tablet bottle.